40-3
40th Parliament,
3rd Session
(March 3, 2010 - March 26, 2011)
Select a different session
Meeting Detail
Televised live on PTN
Wednesday, October 6, 2010
4:14 p.m. ET
Location:
Room 2, Victoria Building
Clerk:
Jessica Richardson
(613) 990-6087
Study on Canada's pandemic preparedness.
Witnesses
- Jeff Aramini, Senior Consulting Epidemiologist (Rx Canada)
- Meena Ballantyne, Assistant Deputy Minister, Health Products and Food Branch (Health Canada)
- Francine Brisebois, Senior Director, Commercial and Consumer Products Directorate (Public Works and Government Services Canada)
- Janet Cooper, Senior Director, Membership and Professional Affairs (Canadian Pharmacists Association)
- Elwyn Griffiths, Director General, Biologics and Genetic Therapies Directorate (Health Canada)
- Jim Hall, Vice-President, Urgent Care (Roche Canada)
- Anne-Marie Hayes, Business Manager, Government, Urgent Care (Roche Canada)
- Henry Kreker, Manager, Influenza Vaccine Project (Public Works and Government Services Canada)
- Dr. Barbara Law, Chief Vaccine Safety, Centre for Immunization and Respiratory Infectious Diseases (Public Health Agency of Canada)
- Paul Lucas, President and CEO (GlaxoSmithKline Canada)
- Wendy Nelson, President and CEO (Rx Canada)
- Jeff Poston, Executive Director (Canadian Pharmacists Association)
- Tom Ring, Assistant Deputy Minister, Acquisitions Branch (Public Works and Government Services Canada)
- Dr. John Spika, Director General, Centre for immunization and respiratory infectious disease (Public Health Agency of Canada)
Meeting with interpretation and transcription